- Home
- GDEN vs IRWD Comparison
GDEN vs IRWD Comparison
Compare GDEN & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- IRWD
- Stock Information
- Founded
- GDEN 1998
- IRWD 1998
- Country
- GDEN United States
- IRWD United States
- Employees
- GDEN N/A
- IRWD N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- GDEN Consumer Discretionary
- IRWD Health Care
- Exchange
- GDEN Nasdaq
- IRWD Nasdaq
- Market Cap
- GDEN 727.9M
- IRWD 111.2M
- IPO Year
- GDEN 1999
- IRWD 2010
- Fundamental
- Price
- GDEN $24.73
- IRWD $1.32
- Analyst Decision
- GDEN Buy
- IRWD Buy
- Analyst Count
- GDEN 7
- IRWD 5
- Target Price
- GDEN $34.71
- IRWD $4.94
- AVG Volume (30 Days)
- GDEN 149.0K
- IRWD 1.2M
- Earning Date
- GDEN 11-06-2025
- IRWD 11-06-2025
- Dividend Yield
- GDEN 4.09%
- IRWD N/A
- EPS Growth
- GDEN N/A
- IRWD N/A
- EPS
- GDEN 0.54
- IRWD N/A
- Revenue
- GDEN $649,900,000.00
- IRWD $308,519,000.00
- Revenue This Year
- GDEN N/A
- IRWD N/A
- Revenue Next Year
- GDEN $2.26
- IRWD N/A
- P/E Ratio
- GDEN $45.20
- IRWD N/A
- Revenue Growth
- GDEN N/A
- IRWD N/A
- 52 Week Low
- GDEN $22.66
- IRWD $0.53
- 52 Week High
- GDEN $35.49
- IRWD $5.13
- Technical
- Relative Strength Index (RSI)
- GDEN 45.06
- IRWD 64.12
- Support Level
- GDEN $24.08
- IRWD $1.05
- Resistance Level
- GDEN $24.81
- IRWD $1.35
- Average True Range (ATR)
- GDEN 0.55
- IRWD 0.09
- MACD
- GDEN 0.14
- IRWD -0.00
- Stochastic Oscillator
- GDEN 52.27
- IRWD 88.89
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.